These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 25318228

  • 1. [Assessment of novel antidiabetic drugs in Germany. Do innovations still have a chance?].
    Gallwitz B.
    MMW Fortschr Med; 2014 Jul 24; 156(13):57-60. PubMed ID: 25318228
    [No Abstract] [Full Text] [Related]

  • 2. [New, expensive antidiabetics for the treatment of type-2 diabetes--pro].
    Müller-Wieland D.
    Dtsch Med Wochenschr; 2010 May 24; 135(18):922. PubMed ID: 20425678
    [No Abstract] [Full Text] [Related]

  • 3. [How AMOG limits the supply of diabetes drugs].
    Oberhofer E.
    MMW Fortschr Med; 2015 Aug 20; 157(14):24. PubMed ID: 26289868
    [No Abstract] [Full Text] [Related]

  • 4. No better than less expensive drugs.
    Perry TL, Lippman SS, McConnell M, Tejani AM.
    BMJ; 2012 Apr 24; 344():e2914. PubMed ID: 22531805
    [No Abstract] [Full Text] [Related]

  • 5. [Investigation today for practice tomorrow].
    Klein H.
    Dtsch Med Wochenschr; 2013 May 24; 138(18):933. PubMed ID: 23613370
    [No Abstract] [Full Text] [Related]

  • 6. [New, expensive antidiabetics for the treatment of type-2 diabetes--contra].
    Nawroth P.
    Dtsch Med Wochenschr; 2010 May 24; 135(18):923. PubMed ID: 20425679
    [No Abstract] [Full Text] [Related]

  • 7. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L, Köster I, Hauner H.
    Med Klin (Munich); 2006 May 15; 101(5):384-93. PubMed ID: 16685485
    [Abstract] [Full Text] [Related]

  • 8. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
    Mathieu C, Bollaerts K.
    Int J Clin Pract Suppl; 2007 Aug 15; (154):29-37. PubMed ID: 17593275
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic indications of incretin-related derivatives and other oral hypoglycemic agents].
    Katsuno T, Miyagawa J.
    Nihon Rinsho; 2012 May 15; 70 Suppl 3():693-8. PubMed ID: 22768600
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [BOT with insulin glargine versus BOT with insulin detemir: comparison of treatment costs in type 2 diabetes based on the results of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study from the German Statutory Health Insurance perspective].
    Schädlich PK, Koltermann KC, Dippel FW, Hagenmeyer EG, Häussler B.
    MMW Fortschr Med; 2010 Oct 14; 152 Suppl 3():89-95. PubMed ID: 21595152
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of type 2 diabetes with new oral antihyperglycaemic drugs].
    Seissler J.
    MMW Fortschr Med; 2008 May 01; 150(18):27-31. PubMed ID: 18533605
    [No Abstract] [Full Text] [Related]

  • 15. Novel therapies for the management of type 2 diabetes mellitus: Part 2. Addressing the incretin defect in the clinical setting in 2013.
    Grunberger G.
    J Diabetes; 2013 Sep 01; 5(3):241-53. PubMed ID: 23489968
    [Abstract] [Full Text] [Related]

  • 16. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
    Freeman JS.
    J Am Osteopath Assoc; 2010 Sep 01; 110(9):528-37. PubMed ID: 20876838
    [Abstract] [Full Text] [Related]

  • 17. [Innovations in the treatment of type 2 diabetes mellitus: use of incretins].
    Dedov II, Shestakova MV, Sukhareva OIu.
    Ter Arkh; 2010 Sep 01; 82(10):5-10. PubMed ID: 21341455
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention and early therapy play too minor a role in our health care system].
    Rothe HJ.
    Med Klin (Munich); 2003 Oct 15; 98 Suppl 1():22-3. PubMed ID: 14694840
    [No Abstract] [Full Text] [Related]

  • 20. Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
    Olansky L.
    Cleve Clin J Med; 2010 Aug 15; 77(8):503-5. PubMed ID: 20682512
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.